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Combined measurement of phenotypic and genetic diversity at single-cell 
resolution. We previously characterized stem cell–like CD44+ and 
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Cellular and genetic diversity in breast 
cancer defined by iFISH analysis. A 
representative example (tumor 2) of 
HER2+ invasive ductal breast carci-
noma with adjacent DCIS displaying a 
high degree of diversity for the expres-
sion of HER2, CD44, and CD24 and for 
copy number gain of ERBB2 and 8q24 
based on immunohistochemical staining 
and iFISH, respectively. CD24 showed 
membrano-cytoplasmic expression in 
invasive tumor cells but apical mem-
branous expression in DCIS. In iFISH, 
blue corresponds to CD24 or CD44 
immunofluorescence; ERBB2 and 
8q24-specific probes are red; and cen-
tromeric probes (chromosomes 17 and 
8 for ERBB2 and 8q24, respectively) 
are green. Faint green and yellow are 
background autofluorescence. Scale 
bars: 10 μm; original magnification, 
×400 (immunohistochemistry) and 
×600 (iFISH).
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Clonal evolution during in situ to invasive breast carcinoma progres-
sion detected by iFISH. iFISH analyses using 11q13/CCDN1 (red) 
and chromosome 11 centromeric probe (green) in a luminal A subtype 
breast cancer (tumor 10). In the invasive areas, both CD44+ and CD24+ 
tumor cells (blue) display high-level amplification, whereas in adjacent 
DCIS, this is restricted to a subset of CD24+CD44+ tumor cells (dotted 
line), with the majority of the tumor demonstrating normal copy number 
for this locus. iFISH analysis of adjacent sections using 8q24 (red) 
and chromosome 8 centromeric probe (green) demonstrates normal 
(2n) copy numbers for 8q24 in both DCIS and invasive areas. Faint 
green and yellow are background autofluorescence. Yellow spots and 
lines are autofluorescent collagen fibers. Scale bars: 10 μm; original 
magnification, ×600.
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Diversity for 8q24 copy number gain in breast tumors. In basal-like tumors, 
CD24+ corresponds to CD44– cells, because no CD24 expression is seen in 
these cases. (A) Box plots depicting the distribution of 8q24 copy number gain 
defined as the ratio of signal observed for the 8q24-specific and centromeric 
probes in 100 individual cells in each of the 4 indicated tumor cell subpopulations. 
The filled circle represents the mean; boxes show the 25th to 75th percentiles; 
the horizontal lines inside the boxes represent the median; whiskers extend to 
the 10th and 90th percentiles; and outlying black circles are individual data points 
outside the 10th and 90th percentiles. Differences are seen between cell popu-
lations and also progression stages both for median copy number gain and for 
range of distribution. (B) Histograms and kernel density estimates depicting the 
distribution of cells with the indicated copy number ratio. Differences are seen 
between DCIS and invasive areas of the same tumor (e.g., tumor 4 [T4]) and also 
between CD24+ and CD44+ cells within the same compartment (e.g., T13A).
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Diversity for 8q24 copy number gain in breast 
tumors defined by Shannon index and Whit-
taker plots. In basal-like tumors, CD24+ cor-
responds to CD44– cells, because no CD24 
expression is seen in these cases. (A) The 
Shannon index, H, indicating diversity within 
tumor cell subpopulations and tumors. For 
each tumor, 100 different cells for each of the 4 
different types (IDC CD24+, IDC CD44+, DCIS 
CD24+, and DCIS CD44+) were analyzed, and 
their Shannon indices are depicted in dark blue, 
dark red, light blue, and light red, respectively. 
Higher score indicates higher diversity. Basal-
like tumors are all uniformly highly diverse for 
8q24, whereas a subset of HER2+ and luminal 
A tumors show a lower degree of diversity. (B) 
Whittaker plots (rank-abundance plots) depict-
ing the abundance of unique cancer cells.
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Cluster analysis of diversity indices
Probe	 Shannon	index	 Simpson’s	index
 Cluster	1	 Cluster	2 P Cluster	1	 Cluster	2 P
 Mean n Mean n  Mean n Mean n	
8q24 (basal-like) 2.309 12 1.495 8 0.696 0.851 16 0.656 4 0.009
8q24 (HER2+) 1.903 17 0.861 6 0.008 0.819 14 0.426 9 0.006
8q24 (luminal A) 1.698 8 0.535 8 0.001 0.773 12 0.282 4 0.003
1q32 1.458 13 1.03 10 0.713 0.716 18 0.535 5 0.488
16p13 1.572 4 0.7 12 0.004 0.74 4 0.417 12 0.003
11q13 1.41 6 0.733 10 0.170 0.672 10 0.401 6 0.297
10p13 1.348 5 1.061 14 0.893 0.662 15 0.492 4 0.901
Cluster analysis of all probes using Shannon and Simpson’s indices as measures of diversity. Shannon and Simpson’s indices were calculated for each 
probe and cell type and clustered into 2 groups using k-means clustering. Significant differences between the 2 clusters were assessed using the paramet-
ric bootstrap method of McLachlan (20). Rows list probe names, while columns indicate mean values, the number of samples in clusters 1 and 2, and the  
P values of their comparison using Shannon and Simpson’s indices. P values are corrected for multiple testing.
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Diversity for different chromosomal probes in 
breast tumor subtypes and their association 
with histopathologic features. (A) Hierarchi-
cal clustering of tumor samples based on the 
Shannon index for the 8q24 probe. Heatmap 
and dendrograms displaying relatedness 
of cell types and tumor samples based on 
their Shannon indices. Red and yellow cor-
respond to high and low diversity, respec-
tively, whereas white represents median 
levels. Tumor names are colored according 
to subtype: red, basal-like; pink, HER2+; and 
blue, luminal A. The color key indicates the 
correlation between diversity and colors. 
(B) Differences in diversity for different chro-
mosomal regions in the same tumor. Histo-
grams of copy number ratios in 4 distinct cell 
types for 3 different chromosomal probes 
are depicted in 2 individual tumors.
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Immunohistochemical and iFISH analyses. iFISH analysis was 
performed essentially as previously described, with minor 














































Associations between diversity and histopathologic variables
Clinical	variable	 Category	 n	 Median	 Q1–Q3	 P
Tumor stage 1 10 1.67 0.59–2.23 0.04
 2 5 1.28 0.65–1.37
Nuclear  1 1 0.48 0.48–0.48 0.04
 pleomorphism 2 4 0.64 0.62–0.83
 3 10 1.7 1.36–2.23
Intratumoral DCIS 0 4 1.12 0.56–1.85 0.01
 1 11 1.37 0.64–1.98
Peritumoral DCIS 0 3 1.28 0.90–1.33 0.01
 1 12 1.64 0.62–2.23
DCIS necrosis 0 3 0.57 0.53–0.61 0.01
 1 12 1.64 1.12–2.23
EIC 0 14 1.33 0.59–1.72 0.01
 1 1 2.27 2.27–2.27
IDC ER 0 11 1.67 1.33–2.23 0.04
 1 4 0.61 0.55–0.64
Significant associations between histopathologic variables and the diversity of 
CD24+ cells in the DCIS portion of the tumors as measured by the Shannon index. 
The columns list the histopathologic variables, category of each variable (defined in 
Supplemental Table 2), number of samples (n), median values, interquartile range 
(Q1–Q3), and uncorrected P values for the associations between histopathologic 
variables and CD24+ cell diversity in the DCIS areas of the tumors determined by 
Kruskal-Wallis test. Once the P values are corrected for multiple testing, none of the 
comparisons are significant.
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